IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.016
AS - Asia 18.671
EU - Europa 14.153
SA - Sud America 2.423
AF - Africa 565
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 20
Totale 58.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.497
CN - Cina 10.054
SG - Singapore 3.975
IE - Irlanda 2.942
UA - Ucraina 2.534
DE - Germania 2.071
BR - Brasile 1.805
FI - Finlandia 1.686
HK - Hong Kong 1.677
VN - Vietnam 1.350
RU - Federazione Russa 1.226
IT - Italia 1.110
FR - Francia 810
SE - Svezia 804
GB - Regno Unito 495
IN - India 350
CA - Canada 286
ZA - Sudafrica 268
BD - Bangladesh 245
AR - Argentina 198
IQ - Iraq 154
MX - Messico 127
NL - Olanda 110
EC - Ecuador 107
TR - Turchia 103
JP - Giappone 99
ID - Indonesia 84
PK - Pakistan 81
CO - Colombia 73
VE - Venezuela 68
MA - Marocco 64
UZ - Uzbekistan 56
ES - Italia 54
PH - Filippine 54
CL - Cile 48
PL - Polonia 48
SA - Arabia Saudita 48
EG - Egitto 47
MY - Malesia 44
TN - Tunisia 43
KE - Kenya 40
PE - Perù 39
JO - Giordania 36
PY - Paraguay 35
IR - Iran 32
BE - Belgio 31
RO - Romania 26
BO - Bolivia 24
LT - Lituania 23
IL - Israele 22
GR - Grecia 21
TH - Thailandia 21
AE - Emirati Arabi Uniti 20
AL - Albania 20
KZ - Kazakistan 20
AZ - Azerbaigian 19
CH - Svizzera 19
NP - Nepal 19
UY - Uruguay 19
AT - Austria 18
CR - Costa Rica 18
DZ - Algeria 18
ET - Etiopia 18
MU - Mauritius 18
NZ - Nuova Zelanda 16
AU - Australia 15
DO - Repubblica Dominicana 15
EU - Europa 15
JM - Giamaica 15
PA - Panama 15
CZ - Repubblica Ceca 14
KG - Kirghizistan 14
NI - Nicaragua 13
BH - Bahrain 12
MK - Macedonia 11
PT - Portogallo 11
SN - Senegal 11
OM - Oman 9
QA - Qatar 9
RS - Serbia 9
KR - Corea 8
KW - Kuwait 8
MD - Moldavia 8
TT - Trinidad e Tobago 8
AM - Armenia 7
HN - Honduras 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
GE - Georgia 6
HU - Ungheria 6
LV - Lettonia 6
DK - Danimarca 5
LB - Libano 5
LK - Sri Lanka 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
EE - Estonia 4
LA - Repubblica Popolare Democratica del Laos 4
SI - Slovenia 4
Totale 58.791
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.396
Dublin 2.942
Chandler 2.846
Nanjing 2.513
San Jose 2.497
Singapore 1.862
Ashburn 1.662
Hong Kong 1.630
Dallas 1.588
Boardman 1.103
Nanchang 1.092
Beijing 969
Princeton 807
Shenyang 768
Hebei 702
Lawrence 700
Changsha 685
Wilmington 655
Lauterbourg 633
Jiaxing 575
Munich 537
Medford 521
Los Angeles 468
Ho Chi Minh City 463
Hangzhou 433
Tianjin 426
Helsinki 419
Hanoi 339
Redondo Beach 302
Buffalo 270
Council Bluffs 249
Johannesburg 229
New York 222
Moscow 203
Milan 199
São Paulo 178
Toronto 149
Shanghai 144
Ann Arbor 138
Santa Clara 123
Seattle 123
Woodbridge 115
Norwalk 111
Tokyo 90
Orem 86
Fairfield 78
Jinan 77
Turku 77
Baghdad 70
Frankfurt am Main 69
Kunming 69
Des Moines 68
Da Nang 63
San Francisco 61
Brooklyn 60
Guangzhou 60
Montreal 60
Rio de Janeiro 58
Chennai 57
Cambridge 56
Quito 53
Ningbo 52
Haiphong 51
Pavia 51
Dhaka 49
Tashkent 49
Chicago 46
Zhengzhou 46
London 45
Verona 43
Phoenix 42
Atlanta 40
Rome 40
Pune 37
Stockholm 36
Warsaw 36
Nairobi 33
Belo Horizonte 32
Guayaquil 32
Amman 30
Campinas 30
Orange 30
Biên Hòa 29
Boston 28
Brussels 28
Mumbai 28
Houston 27
Lahore 27
Mexico City 27
Brasília 26
Hải Dương 26
New Delhi 25
Poplar 25
Charlotte 24
Curitiba 24
Denver 24
Eindhoven 24
Falkenstein 23
Nuremberg 23
Salvador 23
Totale 38.509
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 366
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 339
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 292
Anemia in patients with Covid-19: pathogenesis and clinical significance 288
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 251
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 244
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 202
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 186
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 173
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 160
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 155
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 152
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 150
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 143
Abscisic Acid Treatment in Patients with Prediabetes. 142
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 139
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 134
A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study 133
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 132
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 132
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 131
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 131
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 131
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 130
A comparison study of Lp(a) plasma levels distribution between normo and hypertensive subjects with high BMI 130
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 129
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 129
Adipocytokines levels in obese and non-obese subjects, an observational study 129
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 128
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 127
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 127
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 127
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 127
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 126
Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients 126
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients 125
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 125
Diarrea in paziente diabetico 124
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 123
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 123
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 123
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 123
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 122
Effetti di pioglitazone e rosiglitazone nei pazienti con diabete di tipo 2 e sindrome metabolica trattati con metformina 122
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 122
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 122
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 122
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 122
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 122
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 121
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 121
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 120
Comparison between orlistat and sibutramine in obese patients with mild hypertension 120
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 119
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 119
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 117
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 117
A randomized, double-blind clinical trial on the long term efficacy of psyllium husk vs. guar gum on the clinical features of metabolic syndrome 117
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 116
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 116
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 114
A curious case of hypoglycaemia 113
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 113
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 112
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 112
Aliskiren reduces QT dispersion in hypertensive diabetic patients 112
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 111
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 111
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 111
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 110
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 110
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 110
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 110
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 109
Prevenzione della malattia coronarica: il rischio cardiovascolare globale 109
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 108
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 108
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 107
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 106
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 106
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 106
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 106
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 106
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin in type 2 diabetes patients with metabolic syndrome 106
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 106
A Randomized, Double-Blind, Controlled, Parallel-Group Comparison of Perindopril and Candesartan in Hypertensive Patients with Type 2 Diabetes Mellitus 106
Doxazosin improves blood pressure and metabolic parameters in impaired glucose tolerance patients in therapy with acarbose 106
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 106
COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adults 105
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 105
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 105
Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic insulin-resistant patients 105
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 105
Lipoprotein (a) Particles Characterization by Dynamic Light Scattering 105
Effetti metabolici di telmisartan e di irbesartan in pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone: un trial clinico randomizzato a doppio cieco 104
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 104
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 104
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 103
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 103
Telmisartan ed irbesartan nei diabetii di tipo 2 trattati con rosiglitazone: effetti sull'insulino-resistenza, la leptine e il TNF-alfa 103
Totale 13.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 0 0 130
2021/20222.603 28 7 124 17 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/20258.112 76 807 270 280 146 262 689 756 1.743 123 781 2.179
2025/202618.507 1.383 1.355 2.313 2.041 1.850 777 3.783 786 1.563 1.422 909 325
Totale 59.475